Welcome to our dedicated page for IBEX SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IBEX Limited SEC filings document the company's public-company reporting for its business process outsourcing and AI-powered customer experience operations. Recent 8-K filings furnish quarterly and annual financial results, operating outlook updates, press-release exhibits, and Inline XBRL cover data for a Bermuda registrant that identifies as an emerging growth company.
IBEX proxy and governance filings cover annual general meeting matters, board structure, director elections, authority to fill board vacancies, long-term incentive plan approvals, auditor appointment votes, and committee governance. Material-event filings also document board committee changes and other corporate governance disclosures tied to the company's Nasdaq-listed reporting obligations.
IBEX Ltd’s Chief Legal Officer, Christina Alice Trofimuk-O'Connor, reported equity compensation activity. On February 6, 2026, she acquired 19,557 common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
On the same date, 2,176 common shares were disposed of at $34.98 to cover taxes due at vesting. After these transactions, she directly held 31,335 IBEX common shares. One-third of the award vested on February 6, 2026, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028, subject to her continued service.
IBEX Ltd’s Chief Operating Officer, David Martin Afdahl, reported equity compensation activity. On February 6, 2026, he acquired 109,708 common shares at $0 as a restricted stock award tied to performance goals. On the same date, 13,917 shares were disposed of at $34.98 to cover taxes on the vesting. After these transactions, he directly owned 152,902 common shares. The award stems from an April 20, 2022 performance share grant that vests in three equal installments through 2028, contingent on continued service.
IBEX Ltd's Chief Financial Officer, Taylor C. Greenwald, reported equity compensation activity involving the company’s common shares. On February 6, 2026, the CFO acquired 20,000 common shares at $0 per share as a restricted stock award tied to a May 31, 2024 performance share grant based on revenue and EBITDA targets.
On the same date, 2,121 common shares were disposed of at $34.98 per share to cover tax withholding upon vesting. After these transactions, the CFO directly beneficially owned 54,361 common shares. One-third of the performance-based shares vested on February 6, 2026, with additional one‑third tranches scheduled to vest on February 6, 2027 and February 6, 2028, subject to continued service.
IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal reported several equity transactions. On February 11, 2026 he received a grant of 25,000 Restricted Stock Units, each representing one common share, vesting in four equal annual installments starting February 11, 2027, subject to continued service.
On February 6, 2026 he acquired 12,149 common shares at no cost upon vesting of an earlier performance share award tied to revenue and EBITDA targets, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028. That same day he sold 1,660 shares at $34.98 per share, described as shares withheld for tax purposes. After these transactions he directly owned 42,185 common shares.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported equity compensation transactions in IBEX common shares. On February 6, 2026, he acquired 124,582 common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
One-third of this award vested on February 6, 2026, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028, subject to his continued service. On the same date, 18,988 shares were disposed of at $34.98 to cover taxes, leaving Dechant with 305,406 common shares held directly.
IBEX Ltd’s Chief Sales and CS Officer, Bruce Neil Dawson, reported equity awards and related tax withholding in company stock. On February 6, 2026, he acquired 82,519 common shares at $0 per share as a restricted stock award tied to an April 20, 2022 performance share grant that met revenue and EBITDA targets.
These shares vest in three equal parts: one-third vested on February 6, 2026, with additional thirds scheduled for February 6, 2027 and February 6, 2028, contingent on his continued service. On the same date, 12,246 common shares were disposed of at $34.98 per share to satisfy tax withholding on the vesting. After these transactions, he directly owned 77,034 common shares.
IBEX Ltd’s Chief People Officer, Inson Paul Joseph, reported equity compensation activity. On February 6, 2026, he acquired 25,180 IBEX common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
One-third of the award vested on February 6, 2026, with additional one‑third tranches scheduled for February 6, 2027 and February 6, 2028, subject to continued service. On the same date, 2,627 shares were sold at $34.98 to cover taxes upon vesting, leaving him with 27,469 common shares held directly.
IBEX Limited reports strong growth in its quarter ended December 31, 2025, with revenue of $164.2 million, up 16.7% from a year earlier, driven by HealthTech, Retail & E-commerce, Travel, Transportation & Logistics, and digital marketing.
Quarterly net income rose 31.8% to $12.2 million, and diluted EPS increased to $0.83. For the six-month period, revenue grew 16.6% to $315.4 million and net income rose 44.4% to $24.3 million, reflecting margin gains from higher mix in offshore delivery centers.
Operating cash flow reached $22.3 million in the first half versus $8.9 million a year earlier, while debt remained low at $1.4 million and IBEX had $67.3 million available under its revolving credit facilities. The company continued buybacks, repurchasing 169,858 shares for $5.6 million, and highlights ongoing AI-enabled CX solutions and tax holidays that reduce its effective tax rate.
IBEX Limited filed a current report to share that it has released financial results for its second fiscal quarter ended December 31, 2025. On February 5, 2026, the company issued a press release detailing these quarterly results, which is included as Exhibit 99.1. The report notes that this earnings information is being furnished rather than filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.
IBEX Ltd’s Chief AI & Digital Officer has updated her reported shareholdings. The officer now reports direct beneficial ownership of 6,696 common shares. This amended filing corrects the prior holdings disclosure and explains how past equity awards and related tax share sales affect the total.
The explanation notes a November 8, 2024 grant of 3,521 restricted stock units, with 25% vesting on July 1, 2025 and annually thereafter. When the July 1, 2025 portion vested, 315 shares were sold for tax purposes, leaving 565 fully vested shares from this grant.
The filing also describes 490 fully vested performance stock units and a separate grant of 3,000 restricted stock units that vest 25% on September 16, 2026 and annually thereafter. Overall, the document primarily clarifies the structure and status of this executive’s equity-based compensation and current direct share ownership.